These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 37468340)

  • 1. National Trends in Management of Newly Diagnosed Prostate Cancer.
    Maganty A; Kaufman SR; Oerline MK; Lai LY; Caram MEV; Shahinian VB; Hollenbeck BK
    Clin Genitourin Cancer; 2024 Apr; 22(2):10-17. PubMed ID: 37468340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health care delivery system contributions to management of newly diagnosed prostate cancer.
    Krampe N; Kaufman SR; Oerline MK; Hill D; Caram MEV; Shahinian VB; Hollenbeck BK; Maganty A
    Cancer Med; 2023 Aug; 12(16):17346-17355. PubMed ID: 37475511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practice Competition and Treatment of Newly Diagnosed Prostate Cancer.
    Maganty A; Hollenbeck BK; Kaufman SR; Oerline MK; Lai LY; Caram MEV; Shahinian VB
    Urology; 2023 Jul; 177():95-102. PubMed ID: 37146728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National Trends and Predictors of Androgen Deprivation Therapy Use in Low-Risk Prostate Cancer.
    Yang DD; Muralidhar V; Mahal BA; Labe SA; Nezolosky MD; Vastola ME; King MT; Martin NE; Orio PF; Choueiri TK; Trinh QD; Spratt DE; Hoffman KE; Feng FY; Nguyen PL
    Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):338-343. PubMed ID: 28463152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal Trends and the Impact of Race, Insurance, and Socioeconomic Status in the Management of Localized Prostate Cancer.
    Gray PJ; Lin CC; Cooperberg MR; Jemal A; Efstathiou JA
    Eur Urol; 2017 May; 71(5):729-737. PubMed ID: 27597241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The rise and fall of prostate brachytherapy: use of brachytherapy for the treatment of localized prostate cancer in the National Cancer Data Base.
    Martin JM; Handorf EA; Kutikov A; Uzzo RG; Bekelman JE; Horwitz EM; Smaldone MC
    Cancer; 2014 Jul; 120(14):2114-21. PubMed ID: 24737481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propensity-weighted long-term risk of urinary adverse events after prostate cancer surgery, radiation, or both.
    Jarosek SL; Virnig BA; Chu H; Elliott SP
    Eur Urol; 2015 Feb; 67(2):273-80. PubMed ID: 25217421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.
    Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Observation versus initial treatment for men with localized, low-risk prostate cancer: a cost-effectiveness analysis.
    Hayes JH; Ollendorf DA; Pearson SD; Barry MJ; Kantoff PW; Lee PA; McMahon PM
    Ann Intern Med; 2013 Jun; 158(12):853-60. PubMed ID: 23778902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nationally representative trends and geographic variation in treatment of localized prostate cancer: the Urologic Diseases in America project.
    Cary KC; Punnen S; Odisho AY; Litwin MS; Saigal CS; Cooperberg MR;
    Prostate Cancer Prostatic Dis; 2015 Jun; 18(2):149-54. PubMed ID: 25667110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urologist Practice Affiliation and Intensity-modulated Radiation Therapy for Prostate Cancer in the Elderly.
    Hollenbeck BK; Kaufman SR; Yan P; Herrel LA; Borza T; Schroeck FR; Jacobs BL; Skolarus TA; Shahinian VB
    Eur Urol; 2018 Apr; 73(4):491-498. PubMed ID: 28823605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radical Prostatectomy or External Beam Radiation Therapy vs No Local Therapy for Survival Benefit in Metastatic Prostate Cancer: A SEER-Medicare Analysis.
    Satkunasivam R; Kim AE; Desai M; Nguyen MM; Quinn DI; Ballas L; Lewinger JP; Stern MC; Hamilton AS; Aron M; Gill IS
    J Urol; 2015 Aug; 194(2):378-85. PubMed ID: 25711194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial treatment trends in localized/regional prostate carcinoma: 1992-1999.
    Underwood W; Jackson J; Wei JT; Dunn R; Baker E; Demonner S; Wood DP
    Cancer; 2005 Feb; 103(3):538-45. PubMed ID: 15612083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physician variation in management of low-risk prostate cancer: a population-based cohort study.
    Hoffman KE; Niu J; Shen Y; Jiang J; Davis JW; Kim J; Kuban DA; Perkins GH; Shah JB; Smith GL; Volk RJ; Buchholz TA; Giordano SH; Smith BD
    JAMA Intern Med; 2014 Sep; 174(9):1450-9. PubMed ID: 25023650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient-Reported Outcomes Through 5 Years for Active Surveillance, Surgery, Brachytherapy, or External Beam Radiation With or Without Androgen Deprivation Therapy for Localized Prostate Cancer.
    Hoffman KE; Penson DF; Zhao Z; Huang LC; Conwill R; Laviana AA; Joyce DD; Luckenbaugh AN; Goodman M; Hamilton AS; Wu XC; Paddock LE; Stroup A; Cooperberg MR; Hashibe M; O'Neil BB; Kaplan SH; Greenfield S; Koyama T; Barocas DA
    JAMA; 2020 Jan; 323(2):149-163. PubMed ID: 31935027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sharp Decline In Prostate Cancer Treatment Among Men In The General Population, But Not Among Diagnosed Men.
    Borza T; Kaufman SR; Shahinian VB; Yan P; Miller DC; Skolarus TA; Hollenbeck BK
    Health Aff (Millwood); 2017 Jan; 36(1):108-115. PubMed ID: 28069853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends and variations in utilization and costs of radiotherapy for prostate cancer: A SEER medicare analysis from 2007 through 2016.
    Mukherjee K; Small W; Duszak R
    Brachytherapy; 2022; 21(1):12-21. PubMed ID: 34380592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. National trends in prostate cancer screening among older American men with limited 9-year life expectancies: evidence of an increased need for shared decision making.
    Drazer MW; Prasad SM; Huo D; Schonberg MA; Dale W; Szmulewitz RZ; Eggener SE
    Cancer; 2014 May; 120(10):1491-8. PubMed ID: 24523016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variation in prostate cancer treatment and spending among Medicare shared savings program accountable care organizations.
    Modi PK; Kaufman SR; Borza T; Yan P; Miller DC; Skolarus TA; Hollingsworth JM; Norton EC; Shahinian VB; Hollenbeck BK
    Cancer; 2018 Aug; 124(16):3364-3371. PubMed ID: 29905943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in treatment costs for localized prostate cancer: the healthy screenee effect.
    Zeliadt SB; Etzioni R; Ramsey SD; Penson DF; Potosky AL
    Med Care; 2007 Feb; 45(2):154-9. PubMed ID: 17224778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.